皮肤病学临床试验的多样性:一项系统综述
该系统综述评估2010年7月至2015年7月PubMed收录的626项皮肤病学随机对照试验中女性和少数族裔的纳入代表性。结果显示,仅52项国际研究(11.3%)和58项美国研究(59.8%)报告了种族或族裔人口学数据,美国研究报告种族的研究中白人占74.4%。疾病类型与种族多样性程度显著相关,银屑病研究多样性低于痤疮和湿疹研究。
要点
- 皮肤病学随机对照试验中性别和种族/族裔多样性的报告仍显不足。
- 美国以外开展的研究尤其缺乏种族和族裔数据的报告。
- 不同疾病类型的研究种族多样性程度差异显著。
核心结论
- 美国皮肤病学临床试验反映了美国人口日益增长的多样性,但研究队列的性别和种族/族裔多样性报告仍然缺乏,尤其是在美国以外开展的研究中。
研究设计与样本
- 系统综述,通过PubMed数据库检索2010年7月至2015年7月间发表的随机对照试验,关键词包括银屑病、特应性皮炎、痤疮、白癜风、脂溢性皮炎、斑秃和扁平苔藓。
- 共纳入626篇报告随机对照试验的文章,按期刊类型、疾病类型和资金来源比较性别与种族分布。
- 多样性研究队列定义为基于美国人口普查数据,少数种族或族裔参与者超过20%。
主要发现
- 626项随机对照试验中,532项(85.0%)报告了参与者性别。
- 626项国际研究中52项(11.3%)报告了种族或族裔人口学数据;97项仅在美国开展的研究中58项(59.8%)报告了该数据。
- 在所有报告种族的美国随机对照试验中,白人参与者占74.4%。
- 疾病类型与研究队列种族多样性程度显著相关(P < .001):30.0%的美国银屑病研究多样性超过20%,而痤疮研究为73.9%,湿疹研究为91.7%。
关键数值与推荐
- 多样性研究队列定义为少数种族或族裔参与者超过20%,依据美国人口普查数据。
- 疾病类型与研究队列种族多样性程度显著相关(P < .001)。
- 美国银屑病研究中30.0%具有超过20%的种族或族裔多样性,痤疮研究为73.9%,湿疹研究为91.7%。
临床怎么用
- 临床医生在解读皮肤病学随机对照试验结果时,需注意研究队列的种族和族裔多样性报告不足可能影响结果的外推性。
- 针对不同疾病类型,应关注研究人群构成与自身患者群体的匹配程度。
局限性
- 仅检索PubMed数据库,可能遗漏其他数据库收录的随机对照试验。
- 检索时间范围为2010年7月至2015年7月,未涵盖此后发表的研究。
- 多样性定义基于美国人口普查数据,可能不适用于其他国家的研究队列。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Though there have been significant shifts in US demographic data over the past 50 years, research cohorts lack full racial and ethnic representation. There is little data available regarding the diversity of dermatology research cohorts with respect to sex, race, and ethnicity. OBJECTIVE: To characterize and assess the representation of racial and ethnic minorities and women in randomized controlled trials across a range of dermatologic conditions. EVIDENCE REVIEW: All randomized clinical trials (RCTs) were identified between July 2010 and July 2015 within the PubMed database using the following keywords: "psoriasis," "atopic dermatitis," "acne," "vitiligo," "seborrheic dermatitis," "alopecia areata," and "lichen planus." Diverse study populations were defined as including a greater than 20% racial or ethnic minority participants based on US census data. The distributions of sex and race groups in studies were compared by journal type, disease type, and funding source. FINDINGS: Of the 626 articles reporting RCTs included in this analysis, 532 (85.0%) reported the sex of study participants. Overall, 52 of 626 international (11.3%) studies and 58 of 97 studies (59.8%) conducted exclusively within the United States reported on the racial or ethnic demographics of study participants. Across all RCTs exclusively recruited within the United States that reported race, 74.4% of study participants were white. Disease type was significantly associated with the degree of racial diversity (P < .001) within a study cohort: 30.0% of US-based psoriasis had more than 20% racially or ethnically diverse research participants as compared with 73.9% of acne studies and 91.7% of eczema studies. CONCLUSION AND RELEVANCE: Dermatologic clinical trials within the United States reflect the growing diversity of the US population. Reporting of both sex and racial/ethnic diversity of research cohorts is still lacking, especially among studies conducted outside of the United States.
引用
- Charrow A, Xia FD, Joyce C, et al. Diversity in Dermatology Clinical Trials: A Systematic Review. JAMA Dermatol. 2017. PMID: 28055072. doi:10.1001/jamadermatol.2016.4129
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。